They are quite impressive for such a tiny bio-tech.
And of course NOVARTIS which has extended its partnership with Zalicus until October of 2014. So ask yourself, why would these companies, especially Novartis which has a multi billion $ Mrkt Cap collaborate with Zalicus? Hummm... sounds like they are on to something here or they wouldn't even give them the time of day. The big players are always expected to perform at above average for the sake it's share holders rendering the little guy open to ma$$ive upside. When you start to really comb through Zalicus data, reports etc....they are definitely worth taking a chance on.